Corcept Therapeutics Inc (CORT)
55.96
-0.13
(-0.23%)
USD |
NASDAQ |
Nov 21, 16:00
55.96
0.00 (0.00%)
After-Hours: 20:00
Corcept Therapeutics Max Drawdown (5Y): 60.35% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 60.35% |
| September 30, 2024 | 60.35% |
| August 31, 2024 | 60.35% |
| July 31, 2024 | 60.35% |
| June 30, 2024 | 60.35% |
| May 31, 2024 | 61.61% |
| April 30, 2024 | 61.65% |
| March 31, 2024 | 61.65% |
| February 29, 2024 | 61.65% |
| January 31, 2024 | 61.65% |
| December 31, 2023 | 61.65% |
| November 30, 2023 | 61.65% |
| October 31, 2023 | 61.65% |
| September 30, 2023 | 61.65% |
| August 31, 2023 | 61.65% |
| July 31, 2023 | 61.65% |
| June 30, 2023 | 61.65% |
| May 31, 2023 | 61.65% |
| April 30, 2023 | 61.65% |
| March 31, 2023 | 61.65% |
| February 28, 2023 | 61.65% |
| January 31, 2023 | 61.65% |
| December 31, 2022 | 61.65% |
| November 30, 2022 | 61.65% |
| October 31, 2022 | 61.65% |
| Date | Value |
|---|---|
| September 30, 2022 | 61.65% |
| August 31, 2022 | 61.65% |
| July 31, 2022 | 61.65% |
| June 30, 2022 | 61.65% |
| May 31, 2022 | 61.65% |
| April 30, 2022 | 61.65% |
| March 31, 2022 | 61.65% |
| February 28, 2022 | 61.65% |
| January 31, 2022 | 61.65% |
| December 31, 2021 | 61.65% |
| November 30, 2021 | 61.65% |
| October 31, 2021 | 61.65% |
| September 30, 2021 | 61.65% |
| August 31, 2021 | 61.65% |
| July 31, 2021 | 61.65% |
| June 30, 2021 | 61.65% |
| May 31, 2021 | 61.65% |
| April 30, 2021 | 61.65% |
| March 31, 2021 | 61.65% |
| February 28, 2021 | 61.65% |
| January 31, 2021 | 61.65% |
| December 31, 2020 | 61.65% |
| November 30, 2020 | 61.65% |
| October 31, 2020 | 61.65% |
| September 30, 2020 | 61.65% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
60.35%
Minimum
Jun 2024
61.65%
Maximum
Nov 2019
61.54%
Average
61.65%
Median
Nov 2019
Max Drawdown (5Y) Benchmarks
| Catalyst Pharmaceuticals Inc | 64.87% |
| Madrigal Pharmaceuticals Inc | 82.20% |
| ADMA Biologics Inc | 84.77% |
| Alnylam Pharmaceuticals Inc | 42.46% |
| Akebia Therapeutics Inc | 98.61% |